Haematologica · 2016 · 96 citations · 26 references
MedicineNeurologyOncologyNeuro-oncologyNeuropathologyNeuroradiologyCentral Nervous System LymphomaNervous System PathologyNeuro-oncology ImagingNeurologic ImagingNeurological AssessmentAssociated Neurological SymptomsCentral Nervous System LesionsCerebrospinal Fluid AnalysisCerebrospinal Fluid DiagnosticsChronic Leukemias
Abroad array of conditions can lead to neurological symptoms in chronic lymphocytic leukemia patients and distinguishing between clinically significant involvement of the central nervous system by chronic lymphocytic leukemia and symptoms due to other etiologies can be challenging. Between January 1999 and November 2014, 172 (4%) of the 4174 patients with chronic lymphocytic leukemia followed at our center had a magnetic resonance imaging of the central nervous system and/or a lumbar puncture to evaluate neurological symptoms. After comprehensive evaluation, the etiology of neurological symptoms was: central nervous system chronic lymphocytic leukemia in 18 patients (10% evaluated by imaging and/or lumbar puncture, 0.4% overall cohort); central nervous system Richter Syndrome in 15 (9% evaluated, 0.3% overall); infection in 40 (23% evaluated, 1% overall); autoimmune/inflammatory conditions in 28 (16% evaluated, 0.7% overall); other cancer in 8 (5% evaluated, 0.2% overall); and another etiology in 63 (37% evaluated, 1.5% overall). Although the sensitivity of cerebrospinal fluid analysis to detect central nervous system disease was 89%, the specificity was only 42% due to the frequent presence of leukemic cells in the cerebrospinal fluid in other conditions. No parameter on cerebrospinal fluid analysis (e.g. total nucleated cells, total lymphocyte count, chronic lymphocytic leukemia cell percentage) were able to offer a reliable discrimination between patients whose neurological symptoms were due to clinically significant central nervous system involvement by chronic lymphocytic leukemia and another etiology. Median overall survival among patients with clinically significant central nervous system chronic lymphocytic leukemia and Richter syndrome was 12 and 11 months, respectively. In conclusion, clinically significant central nervous system involvement by chronic lymphocytic leukemia is a rare condition, and neurological symptoms in patients with chronic lymphocytic leukemia are due to other etiologies in approximately 80% of cases. Analysis of the cerebrospinal fluid has high sensitivity but limited specificity to distinguish clinically significant chronic lymphocytic leukemia involvement from other etiologies.
26
An autopsy study of 1206 acute and chronic leukemias (1958 to 1982)
Maurice Barcos, Warren W. Lane, Germán A. Gómez et al. · Cancer · 1987 · 270 citations · Full text
Medicine, Hematology, Pathology +14
Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse
Sophie Bernard, Lauriane Goldwirt, Sandy Amorim et al. · Blood · 2015 · 145 citations · Full text
Medicine, Oncology, Pharmacotherapy +10
Julio García‐Suárez, Dunia de Miguel, Isabel Krsnik et al. · American Journal of Hematology · 2005 · 118 citations · Full text
Incidence of progressive multifocal leukoencephalopathy in patients without HIV
Kandace L. Amend, Bruce Turnbull, Nadia Foskett et al. · Neurology · 2010 · 111 citations
Meningeal dissemination in primary CNS lymphoma
L. Fischer, Peter Martus, Michael Weller et al. · Neurology · 2008 · 108 citations